Optimal Management of HIV-Infected Women during Pregnancy and Delivery: An Audit of Compliance with Recommendations

Department of Obstetrics and Gynecology, Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Journal of Women's Health (Impact Factor: 2.05). 11/2009; 18(11):1881-7. DOI: 10.1089/jwh.2008.1167
Source: PubMed


The improvement in quality of life of HIV-infected patients and a reduced risk of vertical transmission have led to an increase in the desire for pregnancy among infected women. We assessed whether local recommendations were followed by HIV-infected mothers and their reasons for noncompliance.
Data on HIV-infected women who delivered between 2002 and 2006 in a large public university hospital in Brussels were collected and analyzed for compliance with recommendations and outcomes.
The evidence suggests that current recommendations were followed in two thirds of the 203 recorded deliveries, as the patients in question (n = 140) came to term with an undetectable viral load and an uninfected newborn. About half of these women delivered vaginally, and 67% had ruptured membranes for less than 4 hours and required no instrumental delivery. Among those for whom optimal conditions for delivery were not met, two newborns were infected.
The current recommendations were followed in only two thirds of the recorded deliveries. To improve results for the future, we have adapted our protocol both by starting antiviral therapy earlier and by assigning nurses to the patients' follow-up to try to promote better compliance to treatment during pregnancy.

1 Follower
7 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hintergrund Ohne medizinische Maßnahmen werden 40% der Kinder HIV1-positiver Schwangerer (HIV: „human immunodeficiency virus“) mit diesem Virus infiziert. Durch Kombination einer antiretroviralen Behandlung der Schwangeren, einer elektiven Sectio vor Beginn der Wehen, der antiretroviralen Postexpositionsprophylaxe des Neugeborenen und Stillverzicht konnte seit 1994 in entwickelten Ländern bei bekannter HIV1-Infektion der Schwangeren die Übertragungsrate von HIV1 auf 1% gesenkt werden. Inzwischen ist sogar bei nicht nachweisbarer HIV-Last vor der Geburt eine vaginale Entbindung möglich. Derzeitige Situation Bedauerlicherweise werden in Deutschland regelmäßig mehr als 1% der Kinder HIV-positiver Schwangerer infiziert. Die Hauptursachen dafür sind einerseits die mangelnde HIV1-Testung in der Schwangerschaft (zurzeit nur 50–70%) sowie andererseits die bei bekannter HIV1-Infektion nicht leitliniengerechte Behandlung der HIV1-positiven Schwangeren und ihrer Neugeborenen. Schlussfolgerung Nur durch regelmäßige Thematisierung in Publikationen und auf Fortbildungen/Kongressen kann eine stärkere Akzeptanz für die in Deutschland praktizierte Opt-in-Strategie der HIV1-Testung (erst nach Aufklärung und Zustimmung) und die korrekte Prophylaxe bei Mutter und Kind implementiert werden.
    Monatsschrift Kinderheilkunde 12/2012; 160(12). DOI:10.1007/s00112-012-2817-z · 0.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although mother-to-child transmission (MTCT) rates are at an all-time low in Western Europe, potentially preventable transmissions continue to occur. Duration of antenatal combination antiretroviral therapy (ART) is strongly associated with MTCT risk. Data on pregnant HIV-infected women enrolled in the Western and Central European sites of the European Collaborative Study between January 2000 and July 2009 were analysed. The proportion of women receiving no antenatal ART or 1-13 days of treatment was investigated, and associated factors explored using logistic regression models. Of 2,148 women, 142 (7%) received no antenatal ART, decreasing from 8% in 2000-2003 to 5% in 2004-2009 (χ(2)=8.73; P<0.01). A further 41 (2%) received 1-13 days of ART. One-third (64/171) of women with 'insufficient' (0 or 1-13 days) antenatal ART had a late HIV diagnosis (in the third trimester or intrapartum), but half (85/171) were diagnosed before conception. Pre-term delivery <34 weeks was associated with receipt of no and 1-13 days antenatal ART (adjusted odds ratios [ORs] 2.9 [P<0.01] and 4.5 [P<0.01], respectively). History of injecting drug use was associated with an increased risk of no ART (adjusted OR 2.9; P<0.01) and severe symptomatic HIV disease with a decreased risk (adjusted OR 0.2; P<0.01). MTCT rates were 1.1% (15/1,318) among women with ≥14 days antenatal ART and 7.4% (10/136) among those with insufficient ART. Over the last 10 years, around one in 11 women in this study received insufficient antenatal ART, accounting for 40% of MTCTs. One-half of these women were diagnosed before conception, suggesting disengagement from care.
    Antiviral therapy 01/2011; 16(6):895-903. DOI:10.3851/IMP1849 · 3.02 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HAART has significantly reduced AIDS-related morbidity in children. However, limited evidence is available from developing countries regarding patterns of opportunistic illnesses. We describe these events and their associated factors in children with AIDS in Brazil. This study is based on two representative retrospective multi-center cohorts including a total 1,859 children with AIDS, infected via mother-to-child transmission (MTCT), between 1983-2002. Opportunistic illnesses were described and analyzed over time. The association of demographic, clinical and operational data with the occurrence of opportunistic diseases was assessed. In total, 1,218 (65.5%) had at least one event of an opportunistic disease. Variables significantly associated with occurrence of these events included: region of residence (OR 2.68-11.33, as compared to the Northern region), age < 1 year at diagnosis (OR 2.56, 95% CI 1.81-3.61, p < 0.001), and non-performance of MTCT prevention measures (OR 1.58, 95% CI 1.21-2.07, p < 0.001). Protective factors included year of HIV diagnosis in the HAART era (OR 0.34, 95% CI 0.15-0.76, p = 0.009) and ART use (OR 0.58, 95% CI 0.44-0.77, p < 0.001). In both periods bacterial infections represented the most common opportunistic events (58.6 vs. 34.7%; p < 0.001), followed by Pneumocystis jirovecii pneumonia (21.9 vs. 13.2%; p < 0.001), and bacterial meningitis/sepsis (16.8 vs. 7.4%; p < 0.001). Despite the significant reduction in recent years, opportunistic illnesses are still common in Brazilian children with AIDS in the HAART era, especially bacterial diseases. The data reinforce the need for scaling up prevention of MTCT, early diagnosis of infection, and improvement of comprehensive pediatric care.
    AIDS Research and Therapy 07/2011; 8(1):23. DOI:10.1186/1742-6405-8-23 · 1.46 Impact Factor
Show more